Fierce Healthcare March 4, 2022
MDClone’s platform generates synthetic data to expand access to research while protecting patient privacy.
Health data company MDClone grabbed $63 million in a series C funding round to power its continued global growth.
The Israeli company provides a self-service data analysis platform that uses synthetic data, which mimic the statistical characteristics of real-world data but aren’t attached to actual patients, to allow fast access to massive data sets for providers and researchers alike.
The company operates in the U.S., Canada and Israel, providing its data exploration and analytics tools to health systems, government entities, payers and life sciences companies.
In the U.S., MDClone has partnered with the Department of Veterans Affairs, the National Institutes of Health, Intermountain...
Today's Sponsors
Today's Sponsor